Skip to main content
Log in

Quantitative histopathology in lymph node-negative breast cancer. Prognostic significance of mitotic counts

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Reliable prognostic factors are needed to improve the stratification of patients with lymph node-negative breast cancer to different therapy modalities. We investigated the prognostic value of quantitative histopathology in a retrospective study of 98 “low-risk” breast cancer patients (T1+2N0M0) with a median follow-up of 9 years. An interactive video system and stereological and morphometric techniques were used to obtain estimates of four nuclear features (mean volume, mean profile area, volume fraction, and profile density), and two mitotic counts [mitotic profile frequency (MF) and mitotic profile density (MD)]. All measurements were performed in fields of vision sampled systematically from the whole tumour area of a routine histological section. Histological grade, histological type, and oestrogen receptor (ER) status was reassessed, whereas tumour diameter and age at diagnosis were recorded from the files. We found that all quantitative histopathological variables and ER status were correlated with histological grade. Single-factor prognostic analyses showed a highly significant value of MF (2p=0.001) and a marginally significant value of MD (2p=0.09), whereas no other variable approached statistical significance (2p≥0.25). In a multivariate Cox analysis, MF was the only parameter of significant independent prognostic value (2p=0.03). Thus, the prognostic value of nuclear features found in previous studies could not be reproduced, whereas the marked value of mitotic counts for prediction of the outcome in patients with breast cancer was confirmed. Mitotic counts are easily obtained and may be of clinical value for identification of high-risk cases among patients with lymph node-negative breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aaltomaa S, Lipponen P, Eskelinen M, et al (1991) Prognostic factors in axillary lymph node-negative (pN-) breast carcinomas. Eur J Cancer 27: 1555–1559

    Google Scholar 

  2. Andersen KW, Mouridsen HT (1988) Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol 27: 627–647

    Google Scholar 

  3. Baak JPA, Dop H van, Kurver PHJ, Hermans J (1985) The value of morphometry to classic prognosticators in breast cancer. Cancer 56: 374–382

    Google Scholar 

  4. Baak JPA, Noteboom E, Koevoets JJM (1989) The influence of fixatives and other variations in tissue processing on nuclear morphometric features. Anal Quant Cytol Histol 11: 219–224

    Google Scholar 

  5. Biesterfeld S, Noll I, Noll E, Wohltmann D, Bocking A (1995) Mitotic frequency as a prognostic factor in breast cancer. Hum Pathol 26: 47–52

    Google Scholar 

  6. Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359–377

    Google Scholar 

  7. Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T, McGuire WL (1989) Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 320: 627–633

    Google Scholar 

  8. Clayton F (1991) Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor. Cancer 68: 1309–1317

    Google Scholar 

  9. Delides GS, Garas G, Georgouli G, et al (1982) Intralaboratory variations in the grading of breast carcinoma. Arch Pathol Lab Med 106: 126–128

    Google Scholar 

  10. Diest PJ van, Baak JPA (1991) The Morphometric Prognostic Index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients. Hum Pathol 22: 326–330

    Google Scholar 

  11. Diest PJ van, Baak JPA, Matze-Cok P et al (1992) Reproducibility of mitosis counting in 2469 breast cancer specimens. Results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 23: 603–607

    Google Scholar 

  12. Early Breast Cancer Trialists' Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet 339: 1–15, 71–85

    PubMed  Google Scholar 

  13. Fisher B, Redmond C, Fisher ER, et al (1988) Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project protocol B-06. J Clin Oncol 6: 1076–1087

    Google Scholar 

  14. Gundersen HJG (1977) Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J Microsc 111: 219–223

    Google Scholar 

  15. Gundersen HJG, Jensen EB (1985) Stereological estimation of the volume-weighted mean volume of arbitrary particles observed on random sections. J Microsc 138: 127–142

    Google Scholar 

  16. Gundersen HJG, Østerby R (1980) Optimizing sampling efficiency of stereological studies in biology: or ‘Do more less well!’. J Microsc 121: 65–73

    Google Scholar 

  17. Hastie TJ, Tibshirani RJ (1990) Generalized additive models, 1st edn. Chapman and Hall, London

    Google Scholar 

  18. Helander KG (1983) Thickness variations within individual paraffin and glycol methacrylate sections. J Microsc 132: 223–227

    Google Scholar 

  19. Jannik I, Diest PJ van, Baak JPA (1994) Comparison of the prognostic value of mitotic activity index (MAI), random MAI (rMAI), volume weighted MAI, and volume weighted rMAI in breast cancer patients. Abstract presented at the 8th International Symposium on Diagnostic Quantitative Pathology, Amsterdam, September

  20. Jensen V, Ladekarl M (1995) Immunohistochemical quantitation of oestrogen receptors and proliferative activity in oestrogen receptor positive breast cancer. J Clin Pathol 48: 429–432

    Google Scholar 

  21. Jensen V, Ladekarl M, Holm-Nielsen P, Melsen F, Sørensen FB (1995) The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node negative breast cancer. J Pathol 176: 343–352

    Google Scholar 

  22. Ladekarl M (1994) The influence of tissue processing on quantitative histopathology in breast cancer. J Microsc 174: 93–100

    Google Scholar 

  23. Ladekarl M (1995) Quantitative histopathology in ductal carcinoma of the breast: prognostic value of mean nuclear size and mitotic counts. Cancer 75: 2114–2122

    Google Scholar 

  24. Ladekarl M, Sørensen FB (1993) Prognostic, quantitative histopathologic variables in lobular carcinoma of the breast. Cancer 72: 2602–2611

    Google Scholar 

  25. Laroye GJ, Minkin S (1991) The impact of mitotic index on predicting outcome in breast carcinoma: a comparison of different counting methods in patients with different lymph node status. Mod Pathol 4: 456–460

    Google Scholar 

  26. Mansour EG, Gray R, Shatila AH, et al (1989) Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med 320: 485–490

    Google Scholar 

  27. McCarty KS Jr, Barton TK, Fetter BF, et al (1980) Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma. Cancer 46: 2851–2858

    Google Scholar 

  28. Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S (1989) Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol 7:1239–1251

    Google Scholar 

  29. Rosner D, Lane WW (1991) Should all patients with node-negative breast cancer receive adjuvant therapy? Identifying additional subsets of low-risk patients who are highly curable by surgery alone. Cancer 68: 1482–1494

    Google Scholar 

  30. Sahin AA, Ro J, Ro JY, et al (1991) Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis. Cancer 68: 549–557

    Google Scholar 

  31. Siitonen SM, Kallioniemi O-P, Isola JJ (1993) Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer. Am J Pathol 142: 1081–1089

    Google Scholar 

  32. Simpson JF, Dutt PL, Page DL (1992) Expression of mitoses per thousand cells and cell density in breast carcinomas: a proposal. Hum Pathol 23: 608–611

    Google Scholar 

  33. Sokal RR, Rohlf FJ (1981) Biometry. The principles and practice of statistics in biological research, 2nd edn. Freeman, New York

    Google Scholar 

  34. Spiessl B, Beahrs OH, Hermanek P, et al (1989) Breast tumours In: UICC International Union Against Cancer (ed): TNM atlas. Illustrated guide to the TNP/pTNM-classification of malignant tumours, 3rd edn. Springer, Berlin Heidelberg New York, pp 173–183

    Google Scholar 

  35. Start RD, Flynn MS, Cross SS, Rogers K, Smith JHF (1991) Is the grading of breast carcinomas affected by a delay in fixation? Virchows Arch [A] 419: 475–477

    Google Scholar 

  36. Stenkvist B, Westman-Naeser S, Vegelius J, Holmquist J, Nordin B, Bengtsson E, Eriksson O (1979) Analysis of reproducibility of subjective grading systems for breast carcinoma. J Clin Pathol 32: 979–985

    Google Scholar 

  37. Stierer M, Rosen H, Weber R (1991) Nuclear pleomorphism, a strong prognostic factor in axillary node-negative small invasive breast cancer. Breast Cancer Res Treat 20: 109–116

    Google Scholar 

  38. Sørensen FB (1992) Quantitative analysis of nuclear size for objective malignancy grading: a review with emphasis on new, unbiased stereologic methods. Lab Invest 66: 4–23

    Google Scholar 

  39. Theissig F, Kunze KD, Haroske G, Meyer W (1990) Histological grading of breast cancer. Interobserver reproducibility and prognostic significance. Pathol Res Pract 186: 732–736

    Google Scholar 

  40. Uyterlinde AM, Baak JPA, Schipper NW, Peterse H, Matze E, Meijer CJL (1990) Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up. Int J Cancer 45: 1–7

    Google Scholar 

  41. Verhoeven D, Bourgeois N, Derde MP, Kaufman L, Buyssens N (1990) Comparison of cell growth in different parts of breast cancers. Histopathology 17: 505–509

    Google Scholar 

  42. Winstanley J, Cooke T, George WD, et al (1991) The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast. Br J Cancer 64: 99–101

    Google Scholar 

  43. World Health Organization (1982) The World Health Organization histological typing of breast tumors, 2nd edn. Am J Clin Pathol 78: 806–816

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ladekarl, M., Jensen, V. Quantitative histopathology in lymph node-negative breast cancer. Prognostic significance of mitotic counts. Vichows Archiv A Pathol Anat 427, 265–270 (1995). https://doi.org/10.1007/BF00203393

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00203393

Key words

Navigation